Stock Market News19 hours 3 Reasons Growth Investors Will Love ResMed (RMD) Zacks
ResMed (RMD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
X17 hours RMDs are due in a week. There are valid reasons to procrastinate — but they pose big risks. MarketWatch
X22 hours Why ResMed (RMD) is a Top Growth Stock for the Long-Term Zacks
X1 day These Stocks Are Moving the Most Today: Honda, Qualcomm, Eli Lilly, ResMed, Tesla, Walmart, Rumble, and More Yahoo Finance
X4 days Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily
X5 days I Don’t Need My RMD Money – What Are My Options? Yahoo Finance
X7 days Year-End RMD Crunch: Will Delaying My First Withdrawal Impact the Next? Yahoo Finance
X1 week 2 New Required Minimum Distribution (RMD) Rules Everyone Must Know Before 2025 Yahoo Finance
X2 weeks Why ResMed (RMD) is a Top Value Stock for the Long-Term Zacks
X2 weeks Zacks.com featured highlights include InterDigital, ResMed, Greenbrier Companies, Charles River Associates and Kontoor Brands Zacks
X2 weeks RMD or PODD: Which Is the Better Value Stock Right Now? Zacks
X3 weeks Here is Why Growth Investors Should Buy ResMed (RMD) Now Zacks
X3 weeks Zacks Industry Outlook Highlights ResMed, Haemonetics, Phibro and Agios Zacks
X3 weeks Here’s Why ResMed (RMD) is a Strong Momentum Stock Zacks
X3 weeks Are You Among the 84% of Retirees Getting This RMD Rule Wrong? Yahoo Finance
X4 weeks I want to move $90,000 around before taking my RMD in two years. What should I do with it? MarketWatch
X4 weeks RMD vs. LMAT: Which Stock Is the Better Value Option? Zacks
X4 weeks Downgrading ResMed Inc. Because It’s Doing Well Seeking Alpha
X4 weeks Zacks.com featured highlights include InterDigital, Greenbrier, Leidos, ResMed and Kontoor Zacks
X4 weeks ResMed: Solid Execution, Pricey Valuation Seeking Alpha
X1 month RMD Rules at 75: Can You Avoid Them While Still Working? Yahoo Finance
X1 month 3 Reasons Why Growth Investors Shouldn’t Overlook ResMed (RMD) Zacks
X1 month ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year Investor's Business Daily
X1 month Read This Before You Take a RMD from Your IRA This Year 24/7 Wall St.
X1 month When to Take Your First RMD: A Guide to Getting It Right Yahoo Finance
X1 month Here’s Why You Should Add RMD Stock to Your Portfolio Now Zacks
X2 months Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think “Yes” Zacks
X2 months Here’s Why ResMed (RMD) is a Strong Growth Stock Zacks
X2 months RMD analysis and Elliott Wave technical forecast [Video] FXStreet
X2 months RMD Timing: Is It Better to Withdraw Early or Late in the Year? Yahoo Finance
X2 months ResMed (NYSE:RMD) Stock Price Down 2.8% – Should You Sell? MarketBeat
X2 months Why ResMed (RMD) is a Top Momentum Stock for the Long-Term Zacks
X2 months Ask an Advisor: Can I Reduce My RMD to $25k to Avoid Taxes on Social Security? Yahoo Finance
X2 months Forsta AP Fonden Raises Stock Position in ResMed Inc. (NYSE:RMD) MarketBeat
X2 months ResMed Inc. (NYSE:RMD) Shares Sold by Cullinan Associates Inc. MarketBeat
X2 months ResMed (NYSE:RMD) Posts Earnings Results, Beats Expectations By $0.17 EPS MarketBeat
X2 months ResMed’s (RMD) Hold Rating Reaffirmed at Needham & Company LLC MarketBeat
X2 months Zacks.com featured highlights Leidos, NetApp, ResMed, Trane Technologies and Travelers Zacks
X2 months ResMed Inc. (RMD) Q1 2025 Earnings Call Transcript Seeking Alpha
X2 months ResMed (RMD) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Zacks
X2 months ResMed (RMD) Surpasses Q1 Earnings and Revenue Estimates Zacks
X2 months ResMed shares rise 3% as Q1 earnings surpass expectations Investing.com
X2 months ResMed Breaks Out As GLP-1 Drugs And Big Tech Help Drive A Quarterly Beat Investor's Business Daily
X2 months Unveiling ResMed (RMD) Q1 Outlook: Wall Street Estimates for Key Metrics Zacks
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.